1 | LLY | Eli Lilly and Company | 9.81% |
2 | CPH: NOVO.B | Novo Nordisk A/S | 4.55% |
3 | ABT | Abbott Laboratories | 4.54% |
4 | RHHBY | Roche Holding AG | 4.09% |
5 | LON: AZN | AstraZeneca PLC | 4.09% |
6 | UNH | UnitedHealth Group Incorporated | 3.92% |
7 | BBIO | BridgeBio Pharma, Inc. | 3.90% |
8 | BSX | Boston Scientific Corporation | 3.47% |
9 | GILD | Gilead Sciences, Inc. | 3.42% |
10 | SWX: NOVN | Novartis AG | 3.31% |
11 | MDT | Medtronic plc | 3.05% |
12 | TMO | Thermo Fisher Scientific Inc. | 2.99% |
13 | VRTX | Vertex Pharmaceuticals Incorporated | 2.80% |
14 | AMGN | Amgen Inc. | 2.62% |
15 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.60% |
16 | MRK | Merck & Co., Inc. | 2.51% |
17 | DHR | Danaher Corporation | 2.35% |
18 | ABBV | AbbVie Inc. | 2.26% |
19 | EW | Edwards Lifesciences Corporation | 2.16% |
20 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 2.15% |
21 | PODD | Insulet Corporation | 2.10% |
22 | REGN | Regeneron Pharmaceuticals, Inc. | 2.09% |
23 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.07% |
24 | BMY | Bristol-Myers Squibb Company | 2.07% |
25 | MCK | McKesson Corporation | 1.97% |
View HRTS holdings |